Morgan Stanley Shares Soar 31.6% YTD: Is Now the Right Time to Buy?

26.11.25 16:02 Uhr

Werte in diesem Artikel
Aktien

144,80 EUR 1,68 EUR 1,17%

12,00 EUR 0,00 EUR 0,00%

Indizes

PKT PKT

18.057,5 PKT 245,5 PKT 1,38%

3.428,1 PKT 28,6 PKT 0,84%

6.829,0 PKT 63,2 PKT 0,93%

Morgan Stanley MS shares have surged 31.6% this year, outperforming the industry, the Zacks Finance sector and the S&P 500. While it fared better than its close peer, JPMorgan JPM, it lagged Goldman Sachs GS.Price PerformanceImage Source: Zacks Investment ResearchBullish investor sentiments toward Morgan Stanley are largely driven by a rebound in global mergers & acquisitions (M&A). Global M&As in the third quarter of 2025 were impressive, rebounding from the lows recorded in April and May following President Donald Trump’s announcement of sweeping tariffs. As corporates adapt to the rapidly evolving geopolitical and macroeconomic scenarios, deal-making activity has picked up.Can Morgan Stanley’s stock continue to benefit from the ongoing strength in M&A activity, or is a correction likely following the recent rally in share price? Let’s find out.Factors That Support Morgan Stanley StockIncreased Focus on Wealth & Asset Management Operations: Morgan Stanley has lowered its reliance on capital markets for income generation. It has now been focusing on expanding its wealth and asset management operations. The buyouts of Eaton Vance, E*Trade Financial and Shareworks are steps in this direction. Further, in October, Morgan Stanley agreed to acquire EquityZen to tap the rapidly growing private markets landscape. These moves bolster the company’s diversification efforts, enhance stability and create a more balanced revenue stream across market cycles.The wealth and asset management businesses’ aggregate contribution to total net revenues jumped to more than 55% in 2024 from 26% in 2010. In the first nine months of 2025, their aggregate contribution to net revenues was 53%. The Wealth Management (WM) segment’s total client assets witnessed a five-year (2019-2024) compound annual growth rate (CAGR) of 18.1%, while the Investment Management (IM) segment’s total assets under management saw a CAGR of 24.7%. The uptrend for both metrics continued in the first nine months of 2025. The momentum is expected to continue as the operating environment becomes more favorable, given greater clarity on trade and tariffs.Strategic Collaborations: MS’ partnership with Mitsubishi UFJ Financial Group, Inc. will likely continue to support its profitability. In 2023, the companies announced plans to deepen their 15-year alliance by merging certain operations within their Japanese brokerage joint ventures. The new partnership saw combined Japanese equity research, sales and execution services for institutional clients at Mitsubishi UFJ Morgan Stanley Securities and Morgan Stanley MUFG Securities. Also, their equity underwriting business has been rearranged between the two brokerage units. These efforts will solidify the company’s position in Japan’s market.This has helped Morgan Stanley achieve record equity net revenues, particularly in Asia, through outperformance in prime brokerage and derivatives, led by solid client activity amid heightened volatility. The company’s Asia region revenues jumped 29% year over year to $7.27 billion in the first nine months of 2025.Robust Balance Sheet Position: As of Sept. 30, 2025, Morgan Stanley had long-term debt of $324.1 billion, with $25.4 billion expected to mature over the next 12 months. The company’s average liquidity resources were $368.1 billion as of the same date.Morgan Stanley’s capital distribution plans have been impressive. Following the clearance of the 2025 stress test, it announced an 8% hike in quarterly dividend to $1.00 per share. It reauthorized a multi-year share repurchase program of up to $20 billion (no expiration date). The company has increased its dividend five times in the last five years, with an annualized growth rate of 20.4%.Given a solid liquidity position and earnings strength, Morgan Stanley is expected to be able to continue with efficient capital distribution activities, thereby enhancing shareholder value.Bullish Analyst Estimates for MSOver the past week, the Zacks Consensus Estimate for 2025 and 2026 earnings has been revised marginally upward to $9.76 and $10.32, respectively.Estimate Revision TrendImage Source: Zacks Investment ResearchThe Zacks Consensus Estimate for Morgan Stanley’s 2025 and 2026 earnings implies year-over-year growth of 22.8% and 5.8%, respectively.Stretched Valuations for Morgan StanleyFrom a valuation perspective, MS stock is currently trading at a forward 12-month price/earnings (P/E) of 16.11X. This is above the industry’s 14.09X.Forward 12-Month P/EImage Source: Zacks Investment ResearchOn the other hand, JPMorgan and Goldman Sachs have a forward P/E of 14.49X and 14.78X, respectively. This reflects that Morgan Stanley is expensive compared to its peers.How to Play Morgan Stanley StockMorgan Stanley’s efforts to become less dependent on capital markets-driven revenues, inorganic expansion efforts/strategic alliances, along with declining rates, are expected to aid financials. Bullish analyst sentiments are another positive.Additionally, Morgan Stanley’s growth initiatives have helped generate higher returns. This is demonstrated by the company’s return on equity (ROE) of 16.4% compared with the industry’s ROE of 12.51%.    Return on EquityImage Source: Zacks Investment ResearchOn the other hand, JPMorgan and Goldman have delivered ROE of 17.18% and 15.29%, respectively, reflecting cumulative sectoral tailwind over the years.However, rising expenses will likely hurt the company’s profitability in the near term. High reliance on trading revenues is another headwind. Further, a stretched valuation poses concern.Nonetheless, an enhanced deal-making backdrop will likely drive Morgan Stanley’s financials. Also, supported by a solid balance sheet position, the company is expected to be able to meet near-term debt obligations, even if the economic situation worsens. Hence, this seems to be the right time to buy Morgan Stanley shares before they soar further.At present, the company sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.Free Report: Profiting from the 2nd Wave of AI ExplosionThe next phase of the AI explosion is poised to create significant wealth for investors, especially those who get in early. It will add literally trillion of dollars to the economy and revolutionize nearly every part of our lives.Investors who bought shares like Nvidia at the right time have had a shot at huge gains.But the rocket ride in the "first wave" of AI stocks may soon come to an end. The sharp upward trajectory of these stocks will begin to level off, leaving exponential growth to a new wave of cutting-edge companies.Zacks' AI Boom 2.0: The Second Wave report reveals 4 under-the-radar companies that may soon be shining stars of AI’s next leap forward.Access AI Boom 2.0 now, absolutely free >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report The Goldman Sachs Group, Inc. (GS): Free Stock Analysis Report JPMorgan Chase & Co. (JPM): Free Stock Analysis Report Morgan Stanley (MS): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Morgan Stanley und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Ausgewählte Hebelprodukte auf CGI Group

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf CGI Group

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Morgan Stanley

Wer­bung

Analysen zu Morgan Stanley

DatumRatingAnalyst
16.07.2024Morgan Stanley NeutralUBS AG
19.04.2023Morgan Stanley BuyJefferies & Company Inc.
14.04.2022Morgan Stanley BuyGoldman Sachs Group Inc.
28.09.2021Morgan Stanley HoldJoh. Berenberg, Gossler & Co. KG (Berenberg Bank)
20.04.2021Morgan Stanley kaufenCredit Suisse Group
DatumRatingAnalyst
19.04.2023Morgan Stanley BuyJefferies & Company Inc.
14.04.2022Morgan Stanley BuyGoldman Sachs Group Inc.
20.04.2021Morgan Stanley kaufenCredit Suisse Group
15.10.2020Morgan Stanley OutperformRBC Capital Markets
05.10.2020Morgan Stanley OutperformRBC Capital Markets
DatumRatingAnalyst
16.07.2024Morgan Stanley NeutralUBS AG
28.09.2021Morgan Stanley HoldJoh. Berenberg, Gossler & Co. KG (Berenberg Bank)
02.04.2020Morgan Stanley neutralDeutsche Bank AG
21.01.2020Morgan Stanley NeutralCitigroup Corp.
04.04.2019Morgan Stanley HoldHSBC
DatumRatingAnalyst
20.01.2016Morgan Stanley SellSociété Générale Group S.A. (SG)
25.07.2011Morgan Stanley underperformRBC Capital Markets
02.10.2009Morgan Stanley underperformCalyon Securities Inc.
31.08.2005Morgan Stanley underweightPrudential Financial
28.07.2005Morgan Stanley underweightPrudential Financial

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Morgan Stanley nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen